Akari Therapeutics (AKTX)
0.90
-0.04 (-3.95%)
At close: Mar 04, 2025, 11:48 AM
Akari Therapeutics Ratios Statement
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 |
PE Ratio | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.01 | -0.02 | -0.05 | -0.03 | -0.01 | -0.01 | -0.01 | -0.01 | -0.03 |
PEG Ratio | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | 0.00 | -0.00 | 0.00 | 0.00 | 0.00 | -0.00 | 0.00 | -0.00 | n/a |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | -0.03 | 0.01 | 0.01 | 0.00 | 0.00 | 0.02 | 0.03 | 0.02 | 0.03 | 0.02 | 0.01 | -0.01 | -0.01 | n/a |
P/FCF Ratio | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.01 | -0.02 | -0.03 | -0.25 | -0.01 | -0.01 | -0.01 | -0.02 | -0.06 |
P/OCF Ratio | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.01 | -0.02 | -0.03 | -0.25 | -0.01 | -0.01 | -0.01 | -0.02 | -0.06 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | 0.00 | -0.27 | n/a | n/a |
Quick Ratio | 0.95 | 1.35 | 1.91 | 3.47 | 2.07 | 5.98 | 3.19 | 3.90 | 3.30 | 4.73 | 6.36 | 0.29 | 0.01 | n/a |
Current Ratio | 0.95 | 1.15 | 1.91 | 3.37 | 1.88 | 5.33 | 3.19 | 3.90 | 3.30 | 4.73 | 6.36 | 0.29 | 0.01 | n/a |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.98 | -10.01 | n/a | -17.85 | -3.52 | n/a | -158.4 |
Return on Equity (ROE) | 43.70 | -3.89 | -3.17 | -1.42 | -5.67 | -1.49 | -1.4 | -0.53 | -0.93 | -1.99 | -0.62 | 0.43 | 0.85 | n/a |
Return on Assets (ROA) | -2.3 | -0.5 | -1.51 | -1 | -2.11 | -1.21 | -0.96 | -0.4 | -0.65 | -1.49 | -0.46 | -1.28 | -78.48 | n/a |
Return on Capital (ROIC) | 73.39 | -12.89 | -3.1 | -1.45 | -5.13 | -1.49 | -1.75 | -0.8 | -0.63 | -1.99 | -0.55 | 1.34 | 1.02 | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |